author-photo

Nt Ueno

University of Texas MD Anderson Cancer Center

144

Papers

245

Citations

Citation Trend

Filter By

Papers (93) Sort By

Journal Conference Others

Predictors of Overall Survival among Hormone Receptor Positive Patients with Oligometastatic Breast Cancer

2020 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-05-04: Myc as a poor prognostic marker for ER+ inflammatory breast cancer (IBC): Quantitative estrogen receptor (ER) expression analysis and gene expression analysis in ER+ IBC vs non-IBC

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-05-10: Estrogen receptor β suppresses metastasis of inflammatory breast cancer by regulating cell cytoskeleton and cytokine signaling

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-17-06: Immune modulation with humanized anti-EGFR antibody panitumumab in an immunocompetent mouse model for inflammatory breast cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-15-06: Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-02-05: Apocrine morphology and LAR molecular subtype predict prognosis of TNBC patients with residual disease after neoadjuvant chemotherapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT3-05-04: Phase II study of atezolizumab, cobimetinib, and eribulin in patients with recurrent or metastatic inflammatory breast cancer (IBC)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P3-10-23: Changes in the expression of HER2 and other genes in HER2-positive metastatic breast cancer induced by treatment with ado-trastuzumab emtansine and/or pertuzumab/trastuzumab

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P1-18-04: CTCs and SUV to predict the efficacy of the bone-specific radiopharmaceutical agent radium-223 dichloride combined with hormonal therapy for hormone receptor-positive bone-dominant breast cancer metastasis

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)